advanced or metastatic

2 trials

Sponsors

Merck Sharp & Dohme (MSD), European Organisation for Research in Treatment of Cancer (EORTC)

Conditions

bladder cancersoft tissue sarcoma

Phase 3

Maintenance therapy with trabectedin versus observation after first line treatment with doxorubicin of patients with advanced or metastatic soft tissue sarcoma

European Organisation for Research in Treatment of Cancer (EORTC)soft tissue sarcoma

Target: 8Updated: 2024-02-28

A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcinoma

Active, not recruitingNL-OMON45288

Merck Sharp & Dohme (MSD)bladder cancer

Start: 2017-07-14Target: 20Updated: 2024-02-28